Rare Kidney Stone Consortium Biobank
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT02026388
- Status
- Recruiting
Conditions
- APRT Deficiency
- Cystinuria
- Dent Disease
- Primary Hyperoxaluria
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent disease, and from their family members, for use in future research.
Key Dates
- Start date
- May 31, 2013
- Status verified
- Jul 2025
- Primary completion
- Jun 30, 2030
- Completion
- Jun 30, 2030
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: Primary HyperoxaluriaDiagnosis of Primary Hyperoxaluria, or a family member of someone with this diagnosis.
- Arm: Dent DiseaseDiagnosis of Dent Disease, or a family member of someone with this diagnosis.
- Arm: CystinuriaDiagnosis of Cystinuria, or a family member of someone with this diagnosis.
- Arm: APRT deficiencyDiagnosis of APRT Deficiency, or a family member of someone with this diagnosis.
Primary Outcome Measure
Number of samples stored in tissue bank [ Time Frame: 4 years ]
Central Contacts
- Barb M Seide507-255-0387
- Leah M Knoke507-293-0467
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | John C Lieske, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site
Related Studies
- Rare Kidney Stone Consortium Patient RegistryRecruiting · Mayo Clinic · Rochester, Minnesota
- Prospective Research Rare Kidney Stones (ProRKS)Recruiting · Mayo Clinic · Birmingham, Alabama
- Ultrasound for Socket Healing EvaluationRecruiting · University of Michigan · Columbus, Ohio